The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized medicine for brain metastases (BrMets) through patient-derived organoid (PDO) drug testing.
 
Aki Morikawa
Consulting or Advisory Role - Eisai; Lilly; Seagen
Research Funding - Dantari Pharmaceuticals (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); F. Hoffmann LaRoche (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck Sharp & Dohme Corp. (Inst); Merrimack (Inst); Millenium Pharamceuticals (Inst); Molecular Templates (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Suzhou Zanrong Pharma (Inst); Tempus (Inst)
Other Relationship - Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Puma Biotechnology
 
Habib Serhan
No Relationships to Disclose
 
Aaron M. Udager
No Relationships to Disclose
 
Liwei Bao
No Relationships to Disclose
 
Zhaoping Qin
No Relationships to Disclose
 
Xu Cheng
No Relationships to Disclose
 
Jason Heth
No Relationships to Disclose
 
Matthew Soellner
No Relationships to Disclose
 
Sofia Merajver
Employment - InheRET; InheRET
Leadership - InheRET
Stock and Other Ownership Interests - InheRET
 
Nathan Merrill
No Relationships to Disclose